HAVRIONCAPITAL
Back

Investments

Risk Management

Risk management runs through both the assessment of individual investments and the ongoing monitoring of the portfolio, with defined layers and escalation paths that independently test investment judgment.

Risk management provides a layer of review independent from the investment team's own judgment. It is not a compliance step that arrives after a decision has been made; it works alongside the investment team from the preliminary assessment stage onward, identifying and quantifying an investment's exposure across several dimensions and tracking how that exposure changes through the holding period.

Risk dimensions in a single investment

Every investment is systematically assessed across the following dimensions during due diligence, producing an independent risk opinion for the investment committee.

  1. Investment Risk

    An investment thesis rests on a handful of key assumptions — demand growth, the stability of the competitive landscape, management's ability to execute — and the expected outcome shifts once any of those assumptions proves wrong.

  2. Business-Model Risk

    We assess how vulnerable a company's revenue and profit model is to shifts in customer behavior, technology or channel structure, judging whether the model depends on a specific condition that could disappear.

  3. Financial Risk

    We look at leverage, debt maturity structure and the sensitivity of cash flow to a single customer or seasonal factor, judging repayment and operating capacity if revenue declines.

  4. Execution Risk

    We judge where delays or obstacles could arise in transaction structuring, regulatory approval or closing arrangements, and what effect these could have on timeline and terms.

  5. Market Risk

    We assess how the macroeconomic cycle, interest-rate environment and end-demand volatility transmit into a company's operations, distinguishing risk the company can mitigate itself from risk that is wholly external.

  6. Liquidity Risk

    Because investments are held for the long term without a public-market exit available on short notice, we assess whether a company can secure follow-on funding under an unexpected capital need, and whether the portfolio's overall liquidity buffer is adequate.

  7. Concentration Risk

    We assess whether a new investment would push the portfolio's exposure to a particular industry, geography or customer base further into concentration than the portfolio-level tolerance allows.

  8. Governance Risk

    We identify weaknesses in a company's decision-making mechanisms, related-party transactions and disclosure habits, judging whether these can be substantively improved once an outside shareholder is involved.

  9. Technology Risk

    We assess the likelihood that a company's underlying technology path is displaced or becomes outdated, and the ongoing investment needed to stay competitive through technology change.

  10. Regulatory Exposure

    We track regulatory trends in a company's industry, assessing the potential effect of policy change on its business model, cost structure or market access.

  11. Geographic Exposure

    We assess differences in the economic and policy environment across the geographies a company operates in, particularly for companies with cross-border operations or supply chains, judging the added sensitivity that geographic concentration brings.

Three lines of defense
Deal Teams
Forms the first-hand view of risk exposure during due diligence and portfolio management — the front line of risk identification.
Risk Function
Independent of deal teams, reviews and quantifies identified risks and maintains continuous monitoring of portfolio-level exposure.
Investment / Risk Committee
Makes the final judgment on material risk matters and decides on escalated responses where necessary — the last checkpoint in risk governance.

Deal Teams: 1; Risk Function: 2; Investment / Risk Committee: 3

Illustrative framework

Portfolio-level risk

Beyond the assessment of individual investments, the risk function continuously tracks the portfolio's condition as a whole. This includes aggregating exposure across holdings — the portfolio's combined weight in a particular industry or geography, for example — and identifying correlations between companies that may look unrelated: two companies in seemingly different industries can carry linked risk, not independent risk, if they depend on the same point in a supply chain or the same end-demand cycle.

This portfolio-level view is something no single investment's risk opinion can provide on its own: an investment that looks manageable in isolation can still meaningfully raise the portfolio's overall vulnerability if it is highly correlated with exposure the portfolio already carries.

Monitoring cadence and escalation

Deal teams update their risk tracking on their assigned companies quarterly, the risk function conducts an independent review on that basis, and portfolio-level risk is reported on a regular cycle. Most risk matters are handled within this routine rhythm — tracked, reviewed and, where needed, adjusted.

When a risk matter exceeds what deal teams and the risk function can resolve on their own — a material issue found unexpectedly after closing, for instance, or a development at an existing holding that could affect its ability to continue operating — it is escalated to the investment committee, and where warranted, further to the risk committee. The escalation path stays short and clear, without intermediate layers that consume decision time, so material risk matters receive the attention and judgment they need without delay.